trial · primary record
UBT251
Metabolic Dysfunction-associated Steatohepatitis (MASH)
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 156 |
| Primary completion | 2027-08-31 |
| Primary endpoint | Percentage of Participants With MASH resolution With no Worsening of Fibrosis on Liver Histology |
| Registry ID | NCT07145151 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:15.613Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07145151
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Ubt251 · compound